marketcap
Facebook
Twitter
Telegram
Report an ErrorAnnual report 2023
added 03-22-2024
Recro Pharma Financial Ratios 2011-2024 | REPH
Annual Financial Ratios Recro Pharma
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-10.0 | -4.1 | -5.4 | -1.2 | -19.9 | -1.8 | -3.0 | -2.3 | 19.7 | -1.1 | - | - | - |
P/S |
1.4 | 0.9 | 0.8 | 0.5 | 3.7 | 1.9 | 2.1 | 1.0 | 1.1 | - | - | - | - |
EPS |
-0.1 | -0.3 | -0.3 | -1.2 | -0.8 | -3.9 | -2.6 | -2.8 | 0.4 | -2.8 | -15.4 | - | - |
EV (Enterprise Value) |
220 M | 164 M | 155 M | 127 M | 469 M | 281 M | 246 M | 116 M | 138 M | -1.17 M | 1.01 M | 15.7 M | 13.6 M |
EBITDA per Share |
0.05 | 0.13 | 0.16 | -0.1 | 1.26 | -2.09 | -1.3 | -1.29 | -0.165 | -1.9 | - | - | - |
EV/EBITDA |
13.4 | -27.7 | 16.3 | -4.0 | -5.7 | -2.1 | -49.7 | 0.2 | - | - | - | ||
PEG |
0.08 | 0.04 | 0.06 | -0.01 | -0.25 | 0.04 | -0.44 | 0.0 | 0.17 | 0.0 | - | - | - |
P/B |
2.3 | 1.4 | 1.5 | -2.4 | -55.3 | -7.4 | 5.2 | 1.0 | 1.5 | 0.9 | - | - | - |
P/CF |
-132.7 | -22.2 | 5.7 | - | -11.0 | -2.7 | -6.3 | -9.9 | 9.9 | -1.6 | - | - | - |
ROE % |
-22.63 | -33.21 | -27.03 | 195.04 | 277.56 | 408.84 | -173.60 | -42.18 | 7.52 | -85.24 | - | - | - |
ROA % |
-8.65 | -12.63 | -7.09 | -26.59 | -16.87 | -51.27 | -26.89 | -16.51 | 2.19 | -79.19 | - | - | - |
ROCE % |
-6.09 | 0.47 | 0.98 | 59.16 | 24.76 | -35.79 | -20.15 | -9.85 | -2.54 | -62.72 | - | - | - |
Current Ratio |
1.6 | 1.6 | 1.4 | 0.9 | 9.3 | 2.5 | 1.7 | 5.2 | 4.1 | 14.1 | - | - | - |
DSO |
62.7 | 56.4 | 50.7 | 64.3 | 85.5 | 85.3 | 49.2 | 54.8 | 60.5 | - | - | - | - |
DIO |
49.1 | 52.3 | 67.5 | 90.0 | 107.9 | 90.5 | 94.0 | 85.9 | 116.9 | - | - | - | - |
DPO |
6.6 | 9.7 | 12.8 | 9.4 | 7.1 | 38.1 | 76.0 | 40.6 | 20.2 | - | - | - | - |
Operating Cycle |
111.8 | 108.7 | 118.2 | 154.2 | 193.4 | 175.7 | 143.2 | 140.7 | 177.4 | - | - | - | - |
Cash Conversion Cycle |
105.2 | 99.0 | 105.4 | 144.8 | 186.3 | 137.6 | 67.2 | 100.1 | 157.2 | - | - | - | - |
All numbers in USD currency
Quarterly Financial Ratios Recro Pharma
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.05 | -0.04 | -0.06 | - | -0.06 | -0.06 | -0.08 | - | -0.07 | 0.03 | -0.23 | - | -0.09 | -0.25 | -0.33 | - | -0.19 | -0.13 | -0.09 | - | -0.64 | -0.62 | -0.65 | - | -0.48 | -0.46 | -0.42 | - | -0.5 | -0.83 | -0.71 | - | -0.24 | -0.17 | -0.53 | - | -0.61 | -0.36 | -3.67 | - | -3.95 | -4.97 | -3.3 | - | - | - | - | - | - | - | - |
EBITDA per Share |
-0.02 | -0.01 | -0.01 | - | 0.01 | 0.01 | 0.02 | - | 0.1 | 0.12 | -0.05 | - | 0.17 | 0.02 | -0.05 | - | 0.52 | 0.55 | 0.27 | - | -0.56 | -0.56 | -0.57 | - | -0.46 | -0.4 | -0.29 | - | -0.19 | -0.51 | -0.34 | - | 0.14 | 0.21 | -0.53 | - | -0.61 | -0.36 | - | - | 0.01 | 0.01 | - | - | - | - | - | - | - | - | - |
ROE % |
-31.61 | -33.18 | -35.62 | -28.69 | -36.53 | -34.92 | -21.89 | 74.33 | 89.42 | 112.34 | 150.31 | 112.28 | 176.42 | 225.47 | 225.08 | 135.86 | 203.84 | 207.68 | 230.62 | 197.06 | 165.67 | 66.30 | -29.59 | -90.12 | -97.63 | -73.75 | -54.07 | -27.65 | -32.99 | -30.81 | -23.05 | -18.83 | -43.73 | -63.30 | -74.81 | -66.85 | -64.04 | -36.34 | -17.89 | 8.76 | 8.76 | 5.96 | 2.28 | - | - | - | - | - | - | - | - |
ROA % |
-10.51 | -9.68 | -9.56 | -7.04 | -9.25 | -9.26 | -6.22 | -8.75 | -10.81 | -10.66 | -17.48 | -15.31 | -19.21 | -21.05 | -17.80 | -8.26 | -16.78 | -21.41 | -27.02 | -24.71 | -29.57 | -25.91 | -22.49 | -13.96 | -16.90 | -14.98 | -14.53 | -10.82 | -12.37 | -10.99 | -7.62 | -5.48 | -28.61 | -50.19 | -62.96 | -62.11 | -121.31 | -157.38 | -221.37 | -184.94 | -184.94 | -125.73 | -48.03 | - | - | - | - | - | - | - | - |
ROCE % |
-8.83 | -5.20 | -2.61 | -0.75 | 0.00 | 0.15 | 6.31 | 40.55 | 22.94 | 4.58 | 4.82 | 7.83 | -132.69 | -255.62 | -410.86 | -344.96 | -275.46 | -65.42 | 151.06 | 203.84 | 166.73 | 60.13 | -41.01 | -95.10 | -100.58 | -68.95 | -45.72 | -21.95 | -22.35 | -17.28 | -6.91 | -9.74 | -34.67 | -59.19 | -74.88 | -39.70 | -39.70 | -14.77 | - | - | - | - | - | - | - | - | - | - | - | - | - |
Current Ratio |
1.6 | 1.6 | 1.6 | 1.6 | 1.3 | 1.3 | 1.4 | 1.4 | 1.4 | 1.3 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.2 | 1.2 | 1.2 | 1.2 | 1.6 | 1.6 | 1.6 | 1.6 | 1.4 | 1.4 | 1.4 | 1.4 | 14.1 | 14.1 | 14.1 | 14.1 | 0.1 | 0.1 | 0.1 | 0.1 | - | - | - | - | - | - | - | - |
DSO |
58.6 | 64.4 | 66.1 | - | 71.1 | 60.4 | 56.0 | - | 66.4 | 63.9 | 58.3 | - | 42.7 | 53.1 | 49.1 | - | 52.0 | 42.0 | 49.6 | - | 64.2 | 54.0 | 52.6 | - | 51.6 | 52.2 | 48.9 | - | 56.0 | 55.0 | 48.8 | - | 47.3 | 42.0 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
57.7 | 64.3 | 51.8 | - | 50.5 | 46.6 | 52.1 | - | 60.0 | 61.1 | 64.4 | - | 90.2 | 91.1 | 66.7 | - | 124.7 | 97.5 | 81.7 | - | 115.2 | 80.9 | 89.3 | - | 130.5 | 85.9 | 80.8 | - | 138.9 | 83.6 | 78.8 | - | 81.6 | 87.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
13.9 | 16.6 | 9.1 | - | 15.3 | 10.2 | 10.3 | - | 10.7 | 10.0 | 10.6 | - | 14.0 | 14.2 | 7.0 | - | 8.2 | 6.4 | 10.0 | - | 48.6 | 34.1 | 54.2 | - | 105.5 | 69.5 | 52.5 | - | 65.6 | 39.5 | 25.2 | - | 14.1 | 15.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
116.3 | 128.7 | 117.8 | - | 121.6 | 107.0 | 108.1 | - | 126.5 | 125.0 | 122.7 | - | 133.0 | 144.2 | 115.8 | - | 176.7 | 139.6 | 131.3 | - | 179.4 | 134.9 | 142.0 | - | 182.1 | 138.1 | 129.7 | - | 195.0 | 138.6 | 127.6 | - | 129.0 | 129.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
102.4 | 112.1 | 108.7 | - | 106.3 | 96.8 | 97.8 | - | 115.8 | 115.0 | 112.1 | - | 119.0 | 130.0 | 108.8 | - | 168.5 | 133.2 | 121.3 | - | 130.9 | 100.8 | 87.8 | - | 76.6 | 68.7 | 77.2 | - | 129.3 | 99.1 | 102.3 | - | 114.9 | 114.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency